Moroctocog alfa

BIOLOGICAL2 trials

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer

Conditions

Hemophilia A

Phase 3

Study Evaluating The Efficacy And Safety Of Xyntha In Children Less Than 6 Years Of Age

TerminatedNCT00759655

Wyeth is now a wholly owned subsidiary of PfizerHemophilia A

Start: 2009-06-30End: 2009-12-31Updated: 2022-06-15

Unknown Phase

Study Evaluating Refacto For Pharmacovigilance

CompletedNCT00195442

Wyeth is now a wholly owned subsidiary of PfizerHemophilia A

Start: 1999-07-31End: 2010-01-31Updated: 2011-02-11